Patent Application
Utility
App. No. 16/359,659
· Confirmation No. 9641
VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
Applicant:
Par Pharmaceutical, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2021-02-01 | ABN |
Abandonment | 2 | View | |
| 2020-12-01 | C.AD |
Change of Address | 2 | View | |
| 2020-12-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-10-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 6 | View | |
| 2020-10-02 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-10-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 6 | View | |
| 2020-10-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-10-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-10-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-10-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2020-10-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 7 | View | |
| 2020-10-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2020-07-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-07-23 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-07-23 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-07-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 7 | View | |
| 2020-07-23 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-07-23 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-07-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2020-07-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2020-07-09 | CTNF |
Non-Final Rejection | 59 | View | |
| 2020-07-09 | 892 |
List of references cited by examiner | 4 | View | |
| 2020-07-09 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2020-07-09 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2020-07-09 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2020-07-09 | SRNT |
Examiner's search strategy and results | 51 | View | |
| 2020-07-09 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2020-07-09 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2020-07-09 | 1449 |
List of References cited by applicant and considered by examiner | 13 | View | |
| 2020-07-09 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2020-07-09 | BIB |
Bibliographic Data Sheet | 2 | View | |
| 2020-07-09 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2020-07-09 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2020-07-09 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2020-07-09 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2020-07-07 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-07-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 9 | View | |
| 2020-07-01 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-07-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 7 | View | |
| 2020-06-30 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-06-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 9 | View | |
| 2020-06-25 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-06-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 9 | View | |
| 2020-06-22 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-06-22 | N417 |
Electronic Filing System Acknowledgment Receipt | 8 | View | |
| 2020-06-10 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-06-10 | N417 |
Electronic Filing System Acknowledgment Receipt | 9 | View | |
| 2020-06-01 | ELC. |
Response to Election / Restriction Filed | 1 | View | |
| 2020-06-01 | CLM |
Claims | 4 | View | |
| 2020-06-01 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2020-06-01 | COVID-19 |
Request for extension under COVID-19 | 2 | View | |
| 2020-06-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-06-01 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2020-06-01 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2020-06-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 8 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 48 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 74 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 35 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 58 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 59 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 39 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 210 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 27 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 11 | View | |
| 2020-05-21 | FOR |
Foreign Reference | 12 | View | |
| 2020-05-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2020-05-21 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 13 | View | |
| 2020-05-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-03-17 | OA.POSTCARD |
A courtesy postcard sent by USPTO to users who opt-in for e-Office Action | 1 | View | |
| 2020-03-09 | CTRS |
Requirement for Restriction/Election | 5 | View | |
| 2019-09-12 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2019-09-06 | PA.. |
Power of Attorney | 1 | View | |
| 2019-09-06 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-07-05 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2019-03-28 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2019-03-28 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2019-03-28 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-03-22 | CRFE |
Sequence Listing in Computer Readable Format, No errors found | 9 | View | |
| 2019-03-20 | SEQ.TXT |
Sequence Listing (Text File) | 1 | View | |
| 2019-03-20 | TRNA |
Transmittal of New Application | 2 | View | |
| 2019-03-20 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2019-03-20 | SPEC |
Specification | 1 | View | |
| 2019-03-20 | CLM |
Claims | 4 | View | |
| 2019-03-20 | A.PE |
Preliminary Amendment | 1 | View | |
| 2019-03-20 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2019-03-20 | SEQLIST |
Sequence Listing | 8 | View | |
| 2019-03-20 | CRFS |
CRF Statement that Sequence Listing text file (CRF) and paper/pdf Sequence Listing are the same | 2 | View | |
| 2019-03-20 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-03-20 | N417 |
Electronic Filing System Acknowledgment Receipt | 4 | View | |
| 2019-03-20 | DRW |
Drawings-only black and white line drawings | 10 | View | |
| 2019-03-20 | ABST |
Abstract | 1 | View | |
| 2019-03-20 | CLM |
Claims | 3 | View | |
| 2019-03-20 | SPEC |
Specification | 36 | View | |
| 2019-03-20 | ADS |
Application Data Sheet | 9 | View | |
| 2019-03-20 | WFEE |
Fee Worksheet (SB06) | 1 | View |
Inventors
Matthew Kenney
New Haven, MI
Vinayagam Kannan
Rochester, MI
Attorneys & Agents of Record
Classification
USPC
514/10.9
A61K38/095
A61K9/0019
A61K9/08
A61K31/045
A61K45/06
A61K47/02
A61K47/10
A61K47/12
A61K47/26
G01N30/74
G01N2030/027
Prosecution
- Examiner
- BRADLEY, CHRISTINA
- Art Unit
- 1654
- Customer No.
- 175392
- Docket No.
- 19625471
- Confirmation No.
- 9641
Publication
- Pub. No.
- US20190201476A1
- Pub. Date
- 2019-07-04
Parent
is a Continuation of
→
App. 16/044,082
Filed 2018-07-24
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/688,341
Filed 2017-08-28
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/612,649
· US 9,925,233
Filed 2017-06-02
· Patented Case
Parent
is a Continuation in-part of
→
App. 15/426,693
· US 9,744,209
Filed 2017-02-07
· Patented Case
Parent
is a Continuation in-part of
→
App. 15/289,640
· US 9,687,526
Filed 2016-10-10
· Patented Case
Parent
is a Continuation in-part of
→
App. 14/717,877
· US 9,744,239
Filed 2015-05-20
· Patented Case
Parent
is a Continuation of
→
App. 14/610,499
Filed 2015-01-30
· Abandoned -- Failure to Respond to an Office Action
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH HOLDINGS, LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.),
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-26
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR PHARMACEUTICAL COMPANIES, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-25
from
ASTORA WOMEN'S HEALTH LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC.,
PAR PHARMACEUTICAL, INC.
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2021-09-17
from
ASTORA WOMEN'S HEALTH LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC.,
PAR PHARMACEUTICAL, INC.
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2020-05-26
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/359,659
- Filed
- 2019-03-20
- Pub. No.
- US20190201476A1
- Examiner
- BRADLEY, CHRISTINA
- Art Unit
- 1654
External Links